MaxWell Biosystems introduces its new headquarters in Zurich

Since 2016, MaxWell Biosystems was located in the same premises as the Department of Biosystems Science and Engineering at ETH Zurich in Basel. With the growing team and the need for our own headquarters, we searched and found our new home in Zurich. With the dynamic startup ecosystem, world-class universities, and of course the beautiful lake and mountains, Zurich is a great place for MxW. It is here where we will continue to grow the team, develop new products, and connect to…

Neuroservice and MaxWell Biosystems announce strategic partnership

Neuroservice and MaxWell Biosystems announce strategic partnership to develop HD-MEA assays for human iPSC-derived neurons and other cell cultures Aix-en-Provence, FRANCE and Zurich, SWITZERLAND – October 28, 2020. Today, Neuroservice and MaxWell Biosystems are thrilled to announce a strategic partnership aiming to provide the pharmaceutical industry with a new state-of-the-art CNS in vitro cell electrophysiological solution based on high-density microelectrode array recording of human iPSC-derived neurons and other neuron cultures. The partnership will combine the MaxTwo high-density microelectrode array (HD-MEA)…

MaxWell Biosystems appoints Dr. Marcel Suter as new VP Operations

Zurich, Switzerland – September 30, 2020 MaxWell Biosystems AG is pleased to announce the appointment of Dr. Marcel Suter as the new Vice President of Operations, effective September 1, 2020. In this new position, Dr. Suter will oversee the company’s operational units, including, supply chain, production, logistics, procurement, and quality control. He will report directly to Dr. Urs Frey, CEO. With more than eight years of experience as project manager and as VP Operations at Optotune, an optics company, Dr.…

Capture the activity of thousands of communicating neurons all at once

Latest Neurochip published in Nature Communications Today, a new generation of high-density microelectrode array (HD-MEA) technology has been published in Nature Communications (link). This publication not only demonstrates the excellent performance of the chip, but also describes the large-scale extraction of neuronal metrics, such as axonal conduction velocity, and includes impressive showcases of applications with various neuronal preparations. The developed versatile platform for label-free, live-cell electrical imaging will further accelerate drug discovery and basic research in the field of neuroscience.…

Cell Story Challenge Winners

We are excited to announce the winners of our first Cell Story Challenge. Lill Eva Johansen BCRM, UMC Utrecht, Utrecht University, The Netherlands Neural Circuit Development and Disease Lab – Dr. Jeroen Pasterkamp Research Goal: Interrogating human iPSC-derived motor neurons about nerve conduction in an in vitro model of multifocal motor neuropathy Background and motivation:Multifocal Motor Neuropathy (MMN) is a motor neuron-specific autoimmune neuropathy with the electrophysiological hallmark of conduction block, causing asymmetrical weakness in distal parts of limbs which…

10 Years Venture Kick Ceremony | MaxWell Biosystems is a Global Shaper

MaxWell Biosystems joined the celebration of Venture Kick’s 10-year anniversary last 29 November 2017. Held in Schlieren, the ceremony welcomed 500 guests–all involved in the Swiss innovation, entrepreneurship, and investment community. Venture Kick included a variety of events during the evening, such as a startup exhibition, speeches, guitar concert, and a fashion show. Everyone enjoyed the sumptuous dinner, desserts, and drinks. Global Shapers Venture Kick nominated high-impact startups for each of the ten years since the program started. The Global…

MaxWell Biosystems at European Retina Meeting 2017

From October 5th to the 7th, MaxWell Biosystems hosted a booth at the European Retina Meeting, in Paris, France. The conference attracted retina experts, researchers, and students. Paris was a great host, and MaxWell Biosystems even had the opportunity to attend a gala dinner in the city. MaxWell Biosystems would like to thank the organizers for a job well done!   Conference attendees loved the levitating MaxOne chip on display. Additionally, ERM 2017 gave MaxWell Biosystems the opportunity to debut the brand new Tissue Holder, specifically made for retinal applications.   We’re excited to…

MaxWell Biosystems at iForum 2017 in London

On September 28, 2017, MaxWell Biosystems’ VP of Scientific Affairs, Michele Fiscella, travelled to London to meet with stem cell researchers from academia, and the pharma and biotech industries. Michele presented results from using the MaxOne platform with induced pluripotent stem cells (iPSCs) in a presentation titled, “High-resolution microelectrode array platform for biomarker discovery and novel functional assays with human iPSC-derived neurons.”   After presenting promising results and receiving a positive reception from researchers at iForum, Michele is excited about the potential for using MaxWell Biosystems’…

MaxWell Biosystems technology in “The Secrets of Vision”

MaxWell Biosystems was excited to see Dr. Michele Fiscella, VP Scientific Affairs, featured in “The Secrets of Vision”. Michele discussed the state of vision disease research. The video is part of a film series produced by Systems X, the Swiss Initiative in Systems Biology. “The Secrets of Vision” tracks the increasing importance of research on vision-related diseases — with the end goal of developing effective drugs and treatment. In the feature, Michele explains how high-density microelectrode array systems, such as MaxOne, can accelerate this type of retinal cell research. He comments, “High…

MaxWell Biosystems recognized in Top 100 Swiss Startups 2017

“Top 100 Swiss Startup Award,” September 6, 2017 MaxWell Biosystems is honored to be recognized as one of the Top 100 Swiss startups of 2017! The list is published each year by IFJ and startup.ch and all of the best Swiss startups are included. CEO Urs Frey and CTO Jan Muller attended the awards ceremony in Zurich.   See MaxWell Biosystems and all of the Top 100 startups in Startup Ticker’s Official News Release >>

MaxWell Biosystems Featured at ETH Industry Day 2017

ETH Industry Day, August 29, 2017 With 600 attendees, ranging from ETH researchers to industry experts, ETH Industry Day 2017 brought together the research and industry community to inspire attendees about the current stage of research and technology at ETH. As a spin-off that is successfully bringing technology from academia into industry, MaxWell Biosystems was proud to present. The event was a great opportunity to network with leaders, researchers, and industry members from the ETH community. It was exciting to start discussions across many…

MaxWell Biosystems at the 2017 ISN-ESN Meeting in Paris

From August 20 to 24th, MaxWell Biosystems exhibited a booth at the 2017 Biennial Meeting of the International Society of Neurochemistry in Paris, France. CEO, Dr. Urs Frey, and Dr. Michele Fiscella were excited to discuss how the MaxOne high-resolution electrophysiology platform can be used for applications in neurochemistry with conference attendees. MaxWell Biosystems looks forward to connecting with neurochemistry researchers interested in using MaxOne and MaxTwo for their research.  

MaxWell Biosystems at the Annual Meeting of the Japanese Neuroscience Society (JNS) 2017

MaxWell Biosystems travelled to Chiba, Japan and exhibited at the 40th Annual Meeting of the Japanese Neuroscience Society from July 20th to 23rd. CEO, Dr. Urs Frey, and Dr. Marie Obien were excited to show off both the MaxOne and MaxTwo systems at this year’s Japanese neuroscience conference focused on “Pushing the Boundaries of Neuroscience.” MaxWell Biosystems received a warm reception from the Japanese neuroscience community, and we look forward to connecting with researchers excited about using the MaxOne and MaxTwo. We will return to the conference next year in…

MaxWell Biosystems at ISSCR2017 Annual Meeting

MaxWell Biosystems had a great time at the ISSCR2017 Annual Meeting in Boston. The conference was held on the 14th to 17th of June at the Boston Convention and Exhibition Center. The ISSCR annual meeting brought together stem cell researchers from all over the world  aiming to create strong research networks and new opportunities to push forward the research about degenerative and rare diseases. One of the highlights of the meeting was the talk of Prof. Dr. Shinya Yamanaka, who received a Nobel Prize…

MaxWell Biosystems at venture leaders Life Science 2017 in Boston

From the 12th to the 16th of June MaxWell Biosystems and other nine Swiss Life Science startups participated in the business-boosting venture leaders Life Science program, held in Boston. It was an inspiring week, co-organized by swissnex Boston, with pitching events, company visits, and meetings with VCs and experts. Indeed, it was a great opportunity for the ten selected startups to take the first steps towards global expansion. The ten startups met medtech and biotech industry experts who gave motivating feedback on different aspects of business development. The…

MaxWell Biosystems wins Venture Kick

MaxWell Biosystems passes the final stage of Venture Kick and wins CHF 100’000. After presenting at the final stage, MaxWell Biosystems convinced the Venture Kick jury and secured CHF 100’000, in addition to CHF 30’000 already granted in previous stages. Venture Kick supports the first steps of the realization of a business idea and awards selected start-ups with up to CHF 130’000 seed money. The final stage serves as the culmination of the year-long journey of MaxWell Biosystems with Venture Kick. The journey started last July…

MaxWell Biosystems featured in ETH News

MaxWell Biosystems gets more media coverage. ETH Zurich News features the spin-off company MaxWell Biosystems. The article highlights the company’s core technology developed in Hierlemann Lab (D-BSSE) and the motivation to commercialize thanks to the demand of induced pluripotent stem cell boom. Link to English version >> Link to German version >>

MaxWell Biosystems at Startup Champions Seed Night

  MaxWell Biosystems participated at the startup presentation event  “Startup Champions Seed Night” on the 26th of April in the Rolex Learning Center Forum in EPFL. The event was co-organized by EPFL Alumni, the Innogrants and venturelab. A nice audience of 400 people attended the event.

MaxWell Biosystems as a nominee for De Vigier Award 2017

MaxWell Biosystems was successfully preselected as one of the 10 nominees for the W. A. De Vigier Stiftung award. The Award Ceremony will take place in Solothurn on the 18th of May 2017. The William A. De Vigier foundation provides assistance to young Switzerland entrepreneurs. Since its 28th anniversary, the foundation has distributed over 10 million francs of start-up capital.

MaxWell Biosystems at BNA 2017 Festival of Neuroscience

MaxWell Biosystems exhibited MaxOne at the BNA 2017 Festival of Neuroscience on April 10-13, 2017 at the ICC, Birmingham. BNA 2017 is one of the largest neuroscience conferences in Europe this year organized by the British Neuroscience Association. Our MaxOne high-resolution technology attracted a lot of interest. And this is not just because of our magic levitation device, but much more because it allows to monitor neuronal activity at various scales, from full networks, to single-cell activity and even subcellular features. We…
Contacts






Albisriederstrasse 253
8047 Zurich, Switzerland

+41 44 244 24 24

info@mxwbio.com